Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Kenneth F. Bartizal, PhD
Age : 66
Public asset : 439,634 USD
Linked companies : Cidara Therapeutics Inc
Summary 
Dr. Kenneth F. Bartizal is Chief Development Officer at Cidara Therapeutics, Inc. Dr. Bartizal was previously employed as Chief Development Officer by Trius Therapeutics, Inc., Executive Director & Head-Infectious Diseases by Merck & Co., Inc., Research Scientist by Pfizer Inc., a Faculty Member by Kirksville College of Osteopathic Medicine, Inc., a Faculty Member by Northeast Missouri State University, and a Principal by Pfizer Central Research.

He received his undergraduate degree from the University of Notre Dame, a graduate degree from the University of Notre Dame and a doctorate degree from the University of Notre Dame.


Current positions of Kenneth F. Bartizal, PhD 
NameTitle Since
Cidara Therapeutics Inc
(Biotechnology & Medical Research)
Chief Development Officer 2014


Holdings of Kenneth F. Bartizal, PhD 
NameEquities%Valuation
Cidara Therapeutics Inc (CDTX)
Biotechnology & Medical Research
64,6520.32%462,262 USD


Kenneth F. Bartizal, PhD: Personal Network 


Most Read News 
02/16 WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
02/13 STEPHEN SCHWARZMAN : Blackstone appoints real estate boss Gray as Schwarzman's successor
02/17 STEVE WYNN : Top Company News of the Day
02/15 PETER THIEL : Tech Luminary Peter Thiel Parts Ways With Silicon Valley
02/14 ROBIN LI : Baidu earnings beat forecasts, eyes U.S. listing for video unit iQiyi
02/16 ROMAN ABRAMOVICH : Co-owners of Russia's Nornickel back in fight for control
02/19 PETER THIEL : Top Company News of the Day
02/15 DAVID THOMSON : Thomson Reuters Chairman Criticized Its $17 Billion Deal with Blackstone
02/16 VINCENT BOLLORÉ : Vivendi shares drop as French group's lack of guidance underwhelms
02/13 STEVE WYNN : Top Company News of the Day
More news


© 2018 People and Ownership :   
Advertisement
Kenneth F. Bartizal, PhD : Connections 
Optimer Pharmaceuticals, Inc.
Dana-Farber Cancer Institute, Inc.
Biomedical Sciences Careers Program, Inc.
B&D Consulting LLC
Villages of Indiana
Vir Biotechnology, Inc.
Akili, Inc.
Vineyard Sound Advisors LLC
SV Health Investors LLC
Snp Bio, Inc.
The United States Pharmacopeia



Popular Business Leaders 
Bernard Arnault Jean-michel Aulas Jeff Bezos Martin Blessing Kurt Bock Warren Buffett Jean-pierre Clamadieu Tim Cook Richard Cousins Elmar Degenhart Michael Dell Jamie Dimon Patrick Drahi Carlos Ghosn David Henry Heinrich Hiesinger Carl Icahn Ingvar Kamprad Dara Khosrowshahi Isabelle Kocher Bruno Lafont Daniel Loeb Jack Ma Gérard Mestrallet Laurent Mignon Lakshmi Mittal Rupert Murdoch Elon Musk Michael O'leary Nelson Peltz Sumner Redstone Alexandre Ricard Stéphane Richard Kasper Rorsted Wilbur Ross Eric Schmidt George Soros Rupert Stadler Bernard Tapie Peter Terium Peter Thiel Patrick Thomas François Villeroy De Galhau Meg Whitman John Williamson Thomas Wilson Elaine Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders